BROOKE BREITENBACH: Open Payments
NPI 1063661742 · HERMITAGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,446 in 98 payments from 18 companies in 2025. Trend: 2023 $1,361 · 2024 $1,234 · 2025 $1,446
Food & beverage: $1,446
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $393 |
| UCB, Inc. | 17 | $170 |
| Novartis Pharmaceuticals Corporation | 11 | $136 |
| Amgen Inc. | 6 | $119 |
| ABBVIE INC. | 6 | $99 |
| GENZYME CORPORATION | 2 | $71 |
| REVANCE THERAPEUTICS, INC. | 1 | $65 |
| Organon LLC | 6 | $55 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $47 |
Products named: TREMFYA, Bimzelx, OTEZLA, COSENTYX, SKYRIZI, DUPIXENT, DAXXIFY, Zoryve.
Industry payments across PA — which companies pay providers there.
